Revised Guidance To Clarify Adverse Event Reporting Requirements In Europe
This article was originally published in The Gray Sheet
Executive Summary
The revision of supplemental guidelines to the European Medical Device Directive (MDD) should help further clarify manufacturer obligations for postmarket event reporting, speakers suggested March 2 at IBC Life Sciences' Vigilance & Postmarket Surveillance for Medical Devices conference in London